Blog

At the 22nd Congress of the Croatian Ophthalmological and Optometric Society, Dr. Kristina Lončarić presented results from a randomized study comparing the prescription accuracy and efficiency of anti-glaucoma medications using the "Terapija/Therapy" tool versus current clinical practices. dr. Kristina Lončarić at the Congress The study involved 58 ophthalmologists from across Croatia, including 43 specialists and 15 residents, randomly assigned to two groups with comparable clinical experience in glaucoma patient care. Both groups completed an online form featuring 10 patient case descriptions. They could use any resources typically available in their practice (books, internet, etc.) when selecting therapies. However, Group 1 was required to use the "Terapija/Therapy" tool on Glaukom.hr, while Group 2 was not permitted to use it. The accuracy of drug selection was analyzed in accordance with the guidelines…

Glaucoma.solutions is a portal for the most important information about glaucoma, the choice of therapy and other useful information. Glaucoma is the second leading cause of blindness in Europe. If it is diagnosed in time and properly treated, it is possible to prevent pronounced impairment of visual function or blindness, which greatly affects the quality of life and working ability of patients. Glaucoma treatment, depending on the type and degree, can be medical (most often drops, in some cases tablets and intravenous drugs), and/or laser and surgical procedures. Given the chronic nature of the disease, drug treatment is long-term, and therefore an optimal selection of the drug is required, both in relation to the patient's characteristics, predisposing conditions and diseases, side effects and effectiveness, as well as the ease of application…